ARCHIVES

ODAC Meets at ASCO, Recommends Approval Of Dasatinib For CML.

This article is from The Cancer Letter archive.

Vol. 32 No. 22 | June 9, 2006

Download PDF Visit The Full Archive

Related Articles

Comment period for biospecimen network proposal extended.

January 16, 2004

DCT Board Okays Recompetition of Drug Discovery Groups

October 22, 1993

In Brief: NCI Holding Up Regional Cooperative Group RFA Until Department Approves New Mechanism

February 27, 1981

“You Can’t Legislate Biology,” Higginson Tells AACI Members

February 9, 1979

CCOP Letters Of Intent Reach 232; Frelick Experts 80-90 Percent Of them To Qualify For Applications

September 3, 1982

In Brief: NCI To Move Todaro’s Lab to FCR; Cinnamyl Anthranilate Was Carciogenic In Bioassay

March 28, 1980